VIMIZIM

This brand name is authorized in Austria, Brazil, Canada, Ecuador, Estonia, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, United Kingdom, United States

Active ingredients

The drug VIMIZIM contains one active pharmaceutical ingredient (API):

1 Elosulfase alfa
UNII ODJ69JZG85 - ELOSULFASE ALFA

Elosulfase alfa is a recombinant form of human N-acetylgalactosamine-6-sulfatase (rhGALNS) used for the treatment of mucopolysaccharidosis, type IVA (Morquio A Syndrome, MPS IVA). Elosulfase alfa is intended to provide the exogenous enzyme N-acetylgalactosamine-6-sulfatase that will be taken up into the lysosomes and increase the catabolism of the GAGs KS and C6S.

Read about Elosulfase alfa

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
VIMIZIM Concentrate solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A16AB12 A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 542417020000102
Country: CA Health Products and Food Branch Identifier(s): 02427184
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 69-MBE-0816
Country: EE Ravimiamet Identifier(s): 1647277
Country: FR Base de données publique des médicaments Identifier(s): 61673965
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 341686
Country: HK Department of Health Drug Office Identifier(s): 63775
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 7643
Country: JP 医薬品医療機器総合機構 Identifier(s): 3959417A1027
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1073356
Country: NL Z-Index G-Standaard Identifier(s): 16091973
Country: NL Z-Index G-Standaard, PRK Identifier(s): 124265
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 17526
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100315723
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W66181001
Country: US FDA, National Drug Code Identifier(s): 68135-100

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.